Inventor
Robert L. Coffman
Inventor
Portola Valley, CA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12NMicroorganisms or enzymes16%
C07KPeptides13%
C07HSugars5%
A01KAnimal husbandry4%
A61NElectrotherapy4%
C07DHeterocyclic compounds3%
C25CProcesses for the electrolytic production, recovery or refining of metals3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
11,124,510Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof202110,751,412Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer202010,722,591Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof202010,548,975Branched chimeric compounds, and methods of use thereof202010,369,168Administration of polynucleotide toll-like receptor 9 agonists for treating cancer201910,350,290Linear chimeric compounds and methods of use thereof201910,111,899Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung20189,993,495Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung20189,950,064Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof20189,476,053'Methods and compositions for inhibition of immune responses and autoimmunity'20169,347,064'Methods of treatment using TLR7 and/or TLR9 inhibitors'20169,333,254'Long term disease modification using immunostimulatory oligonucleotides'20169,063,123'Transgenic mice expressing human toll-like receptor 8'20158,962,579'Methods and compositions for inhibition of immune responses and autoimmunity'20158,940,310'Methods of treatment using TLR7 and/or TLR9 inhibitors'20158,815,817'Long term disease modification using immunostimulatory oligonucleotides'20148,759,305'Methods and compositions for inhibition of innate immune responses and autoimmunity'20148,252,757'Long term disease modification using immunostimulatory oligonucleotides'20126,207,155'Method of eosinophil depletion with antibody to CCR 3 receptor'20015,676,940'Method of reducing immunoglobulin E responses'19975,601,815'IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells'19975,096,704'Method of treating eosinophilia'19924,259,161'Process for producing aluminum and electrodes for bipolar cell'19814,121,983'Metal production'19783,974,080'Silicone hydraulic fluids'1976Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1976Based in Mahopac, NY, US· patent location history
1978–1981Based in Lower Burrell, PA, US· patent location history
1992–2001Patents assigned to SCHERING CORP (4)· patent assignee history
1992–2021Based in Portola Valley, CA, US· patent location history
2012–2021Patents assigned to DYNAVAX TECH CORP (18)· patent assignee history
2012–2015Patents assigned to COFFMAN ROBERT L (6)· patent assignee history
2014–2015Patents assigned to BARRAT FRANCK (4)· patent assignee history
2015Patents assigned to GUIDUCCI CRISTIANA (3)· patent assignee history
2020Based in Berkeley, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DYNAVAX TECH CORP | 18 | 2012–2021 |
| COFFMAN ROBERT Lself | 6 | 2012–2015 |
| BARRAT FRANCK | 4 | 2014–2015 |
| SCHERING CORP | 4 | 1992–2001 |
| GUIDUCCI CRISTIANA | 3 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Portola Valley, California, US | 21 | 1992–2021 |
| Lower Burrell, Pennsylvania, US | 2 | 1978–1981 |
| Berkeley, California, US | 1 | 2020 |
| Mahopac, New York, US | 1 | 1976 |